R&D BIO 2024 - Live Coverage pharmaphorum is back at the BIO International Convention this year, coming to you from sunny San Diego with two days of live coverage of one of the year’s biggest pharma executive gathering
News MSD's Sac-TMT delivers in first phase 3 readout MSD's TROP2-targeting antibody-drug conjugate sac-TMT, licensed from China's Kelun, has improved survival in a late-stage endometrial cancer trial.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.